HIV / AIDS in the News

"I take great exception" - Clyde Drexler was furious with the coverage surrounding his alleged Magic Johnson HIV remarks - Basketball Network

 

Weekly Oral HIV Treatment Matches Daily Pills - poz.com

 

Awareness campaign hopes to reduce stigma around HIV through an Indigenous lens - APTN News

 

Can Gilead Sciences HIV Franchise Drive Long-Term Growth? - Yahoo Finance

 

Can Gilead Sciences HIV Franchise Drive Long-Term Growth? - Zacks Investment Research

 

Beyond the Virus: BUSSW Researchers Bring HIV Stigma Research to Harvard Symposium - Boston University

 

Weekly HIV Regimen Meets Phase 3 Goal - Conexiant

 

GSK's Nuvalent deal tackles HIV cliff to win cautious backing from analysts - Proactive financial news

 

(BPRW) PPMW launches summer Spill the Tea ambassadorship for Black Women - Black PR Wire

 

Flu Drugs Show Promise Against Cognitive Decline, Aging-Related Diseases - poz.com

 

As HIV cases rise among young men in Karnataka, dating apps complicate contact tracing - The South First

 

Plunging HIV Budgets Cast Dark Shadow Over UN High-Level Meeting - Health Policy Watch

 

The American Academy of HIV Medicine et al. v. U.S. Department of Health and Human Services et al. - Lambda Legal

 

Health Equity in HIV - Centers for Disease Control and Prevention | CDC (.gov)

 

Phase 3 Trials Support Oral, Once-Weekly Islatravir/Lenacapavir for HIV - Infectious Disease Advisor

 

Pitavastatin Reduces Incident Hypertension Risk in Individuals With HIV - Infectious Disease Advisor

 

South Africa Could Begin Local Manufacturing Of HIV Drug Lenacapavir Generic - Eurasia Review

 

Mehdi Benlarbi awarded the Uta von Schwedler Prize - Université de Montréal

 

Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study - Yahoo Finance

 

GILD: Strong pipeline, strategic acquisitions, and long-acting HIV therapies drive long-term growth - TradingView

 

Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study - Zacks Investment Research

 

Once Weekly Oral HIV Regimen Maintains Viral Suppression - Drug Topics

 

Gilead Balances Trodelvy Setback With Once Weekly HIV Progress - simplywall.st

 

Semaglutide Tied to Aging Clocks in HIV - Conexiant

 

Gilead’s Mixed Trial News Puts HIV Progress And Oncology Risks In Focus - Yahoo Finance

 

Merck, Gilead report mixed outcomes in key lung cancer, HIV studies - BioPharma Dive

 

HIV-Related Stigma and Its Impact Across the HIV Care Continuum: Implications for Testing, Treatment, and Long-Term Retention - Cureus

 

HIV-Related Stigma and Its Impact Across the HIV Care Continuum: Implications for Testing, Treatment, and Long-Term Retention - Cureus

 

Semaglutide and aging: New study finds benefits beyond weight loss - Medical News Today

 

Merck, Gilead score in effort to develop the first weekly HIV pill - Fierce Pharma